KRSA

36.9854.33%
MJ

Mark Joseph Vignola

Chief Financial Officer

Dr. Mark Joseph Vignola, Ph.D. is Chief Financial Officer of Korsana Biosciences, Inc. since March 2026. He had been Chief Financial Officer of Terns Pharmaceuticals, Inc. since August 2020 until January 2025 and had been its Treasurer since January 2021 until January 2025. He served as Chief Financial Officer of Applied Therapeutics, Inc. since April 29, 2019 until May 26, 2020. Prior to joining Applied Therapeutics, Dr. Vignola served as Executive Director, Head of Corporate Development and Investor Relations at Intercept Pharmaceuticals, Inc. He served as Director of Investor Relations at Intercept Pharmaceuticals, Inc. He served as Research Analyst of Biotechnology at Needham & Company, LLC, Research Division till May 2015 He was the part of the healthcare team. He started his career on Wall Street at Lehman Brothers. Dr. Vignola holds a Ph.D. in Molecular Genetics and Microbiology from Duke University School of Medicine and a Bachelor of Science degree in biology from Boston College.

Positions